Observational studyMedicine2026
Identifying the association between hemoglobin levels and metabolic dysfunction-associated steatotic liver disease: An observational study and Mendelian randomization analysis.
Observational study in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Observational studies suggest a relationship between hemoglobin (Hb) levels and metabolic dysfunction-associated steatotic liver disease (MASLD), but its specific nature remains unclear. This study aimed to clarify the association through a National Health and Nutrition Examination Survey (NHANES) cross-sectional analysis and a 2-sample Mendelian randomization (MR) approach. We utilized NHANES data from 49,693 participants (2009-2018). Weighted multivariate logistic regression examined the Hb-MASLD association, with smoothed curve fitting and threshold effect analysis exploring nonlinear relationships. MR analyses assessed the observed causal relationship. Among 6165 NHANES participants, higher Hb levels were positively associated with MASLD risk (odds ratio = 1.15, 95% confidence interval = 1.08-1.23). Notably, when Hb concentrations exceeded 12.9 g/dL, MASLD risk significantly increased (odds ratio = 1.25, 95% confidence interval = 1.18-1.32). Two-sample MR analysis supported a causal relationship between elevated Hb levels and increased MASLD risk. Sensitivity analyses confirmed robustness (all P > .05). This study demonstrates that higher Hb levels are associated with an increased risk of MASLD, revealing potential nonlinear trends. MR analysis further confirmed this causal relationship, suggesting Hb levels could be a target for early intervention in preventing MASLD. These findings underscore the need for additional research to explore Hb's role in MASLD development and to inform clinical guidelines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.